Sustained economic benefits of resistance training in community-dwelling senior women

Journal of the American Geriatrics Society

Volumn 59, Issue 7, 2011, Pages 1232-1237

  Davis, Jennifer C ^a   Marra, Carlo A ^a   Robertson, M Clare ^c   Najafzadeh, Mehdi ^a   Liu Ambrose, Teresa ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

cognition; cost utility analysis; executive functions; older adults; quality adjusted life year

Indexed keywords

AGED; ARTICLE; BODY EQUILIBRIUM; CANADA; COMMUNITY LIVING; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EXERCISE INTENSITY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; KINESIOTHERAPY; MUSCLE TONE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING;

AGED; CANADA; COGNITION DISORDERS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INDEPENDENT LIVING; OUTCOME ASSESSMENT (HEALTH CARE); RESISTANCE TRAINING;

EID: 79960398652     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03474.x     Document Type: Article

References (20)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, et al,. Forecasting the global burden of Alzheimer's disease. Alzheimer Dement 2007; 3: 186-191. (Pubitemid 46825511)
2. Liu-Ambrose T, Donaldson MG, Ahamed Y, et al,. Otago home-based strength and balance retraining improves executive functioning in older fallers: A randomized controlled trial. J Am Geriatr Soc 2008; 56: 1821-1830.
3. Liu-Ambrose T, Nagamatsu LS, Graf P, et al,. Resistance training and executive functions: A 12-month randomized controlled trial. Arch Intern Med 2010; 170: 170-178.
4. Colcombe SJ, Kramer AF, Erickson KI, et al,. Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci U S A 2004; 101: 3316-3321. (Pubitemid 38327778)
5. Cassilhas RC, Viana VA, Grassmann V, et al,. The impact of resistance exercise on the cognitive function of the elderly. Med Sci Sports Exerc 2007; 39: 1401-1407. (Pubitemid 47344023)
6. Baker LD, Frank LL, Foster-Schubert K, et al,. Effects of aerobic exercise on mild cognitive impairment: A controlled trial. Arch Neurol 2010; 67: 71-79.
7. Lautenschlager NT, Cox KL, Flicker L, et al,. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. JAMA 2008; 300: 1027-1037.
8. Chang YK, Etnier JL., Exploring the dose-response relationship between resistance exercise intensity and cognitive function. J Sport Exerc Psychol 2009; 31: 640-656.
9. Mooney G, Wiseman V., Burden of disease and priority setting. Health Econ 2000; 9: 369-372. (Pubitemid 30612140)
10. Wiseman V, Mooney G., Burden of illness estimates for priority setting: A debate revisited. Health Policy 1998; 43: 243-251. (Pubitemid 28162555)
11. Davis JC, Hsiung GYR, Liu-Ambrose T., Challenges moving forward with economic evaluations of exercise intervention strategies aimed at combating cognitive impairment and dementia. Br J Sport Med 2011; 45: 470-472.
12. Drummond MF, Sculpher MJ, Torrance GW, et al,. Methods for the Economic Evaluation for Health Care Programmes, 3rd Ed. New York: Oxford University Press, 2005.
13. Davis JC, Marra CA, Robertson MC, et al,. Economic evaluation of dose-response resistance training in older women: A cost-effectiveness and cost-utility analysis. Osteoporos Int 2011; 22: 1355-1366.
14. Davis JC, Marra CA, Ashe MC, et al,. Economic Evaluation of Dose-Response Resistance Training Among Older Women: A Cost Effectiveness and Cost Utility Analysis. Canadian Agency for Drugs and Technologies in Health. Halifax, Nova Scotia, April 18-20, 2010.
15. Briggs A, Clark T, Wolstenholme J, et al,. Missing - presumed at random: Cost-analysis of incomplete data. Health Econ 2003; 12: 377-392. (Pubitemid 36603549)
16. Manca A, Palmer S., Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials. Appl Health Econ Health Policy 2005; 4: 65-75. (Pubitemid 41324092)
17. Oostenbrink JB, Al MJ., The analysis of incomplete cost data due to dropout. Health Econ 2005; 14: 763-776. (Pubitemid 41093974)
18. Oostenbrink JB, Al MJ, Rutten-van Molken MP., Methods to analyse cost data of patients who withdraw in a clinical trial setting. Pharmacoeconomics 2003; 21: 1103-1112. (Pubitemid 37330551)
19. Briggs AH, Gray AM., Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 1999; 3: 1-134.
20. Fenwick E, Claxton K, Sculpher M., Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Econ 2001; 10: 779-787. (Pubitemid 34041389)